What is the recommended nebulization dose of Asthalin (Salbutamol) for a 9-month-old patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nebulized Salbutamol Dosing for a 9-Month-Old Infant

For a 9-month-old infant with acute asthma or wheezing, administer nebulized salbutamol (Asthalin) at 0.15 mg/kg per dose, which translates to approximately 1.0-1.5 mg per dose for most infants this age, given every 20 minutes for up to 3 doses initially. 1

Weight-Based Dosing Calculation

  • The British Thoracic Society recommends 0.15 mg/kg as the standard weight-based dose for nebulized salbutamol in children. 1
  • For a typical 9-month-old weighing 8-10 kg, this calculates to 1.2-1.5 mg per dose. 1
  • The alternative fixed dose of 5 mg mentioned in guidelines is intended for older children and adults, not infants. 1

Initial Treatment Protocol for Acute Exacerbation

  • Administer the calculated dose (0.15 mg/kg) every 20 minutes for 3 doses as initial therapy. 2, 3
  • Use oxygen as the driving gas whenever possible to maintain oxygen saturation >92%. 1
  • Reassess the infant 15-30 minutes after each dose to determine response. 2, 3

Important Considerations for Infants

  • A metered-dose inhaler with spacer and face mask is actually preferred over nebulization in infants when tolerated, as it is equally effective and more convenient. 1
  • However, if the infant cannot tolerate a face mask with spacer, nebulization is the appropriate alternative. 1
  • Some infants may require a mouthpiece rather than face mask for nebulization, though most 9-month-olds will need a face mask. 1

When to Escalate Therapy

  • If the infant fails to respond adequately after 2-3 doses of salbutamol, add ipratropium bromide 250 mcg to the nebulization and initiate systemic corticosteroids immediately. 1, 2
  • Do not delay corticosteroids while continuing repeated salbutamol doses alone if initial treatment fails. 2
  • Features indicating severe exacerbation in infants include: too breathless to feed, respiratory rate >50/min, pulse >140/min, and use of accessory muscles. 1, 2

Ongoing Treatment After Initial Doses

  • If symptoms improve after initial treatment, continue nebulized salbutamol at the same weight-based dose (0.15 mg/kg) every 4-6 hours as needed. 1
  • For severe cases requiring frequent dosing, doses up to 0.3 mg/kg/hour have been used safely in monitored settings, though this requires intensive care supervision. 1

Common Pitfalls to Avoid

  • Do not use the adult fixed dose of 5 mg in a 9-month-old infant—this represents excessive dosing and increases risk of tachycardia and tremors without additional benefit. 1
  • Do not continue repeated salbutamol doses beyond 3 initial treatments without adding ipratropium and corticosteroids if response is inadequate. 2, 4
  • Receiving fewer than 3 doses of nebulized salbutamol in the emergency setting is associated with treatment failure in children with severe exacerbations. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Asthma Exacerbation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Asthma Exacerbation Management in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.